{"created":"2023-05-15T09:04:39.821029+00:00","id":5789,"links":{},"metadata":{"_buckets":{"deposit":"786ad73f-7c33-4fa8-b3d2-63c106278489"},"_deposit":{"created_by":11,"id":"5789","owners":[11],"pid":{"revision_id":0,"type":"depid","value":"5789"},"status":"published"},"_oai":{"id":"oai:hirosaki.repo.nii.ac.jp:00005789","sets":["557:561:976"]},"author_link":["14940","14947"],"item_3_alternative_title_21":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"Worsened outcome in patients with pancreatic ductal carcinoma on longterm diabetes: association with E-cadherin1 （CDH1） promoter methylation"}]},"item_3_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2019-11-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"87","bibliographicPageStart":"85","bibliographicVolumeNumber":"70","bibliographic_titles":[{"bibliographic_title":"弘前医学"}]}]},"item_3_full_name_2":{"attribute_name":"著者(ヨミ)","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"14947","nameIdentifierScheme":"WEKO"}],"names":[{"name":"サイトウ, タケシ"}]}]},"item_3_publisher_35":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"弘前大学大学院医学研究科・弘前医学会"}]},"item_3_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00211444","subitem_source_identifier_type":"NCID"}]},"item_3_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0439-1721","subitem_source_identifier_type":"ISSN"}]},"item_3_text_4":{"attribute_name":"著者所属","attribute_value_mlt":[{"subitem_text_value":"国際医療福祉大学病院 小児外科"}]},"item_3_version_type_18":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"齋藤, 傑"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-11-22"}],"displaytype":"detail","filename":"HirosakiMedJ_70(1)_85.pdf","filesize":[{"value":"367.7 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"HirosakiMedJ_70(1)_85","url":"https://hirosaki.repo.nii.ac.jp/record/5789/files/HirosakiMedJ_70(1)_85.pdf"},"version_id":"6dc406a0-0b45-4447-a897-862e2dab26fd"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"2 型糖尿病長期罹患により膵導管癌患者の予後は増悪する：E-cadherin1 （CDH1）プロモーター領域のメチル化との関連","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"2 型糖尿病長期罹患により膵導管癌患者の予後は増悪する：E-cadherin1 （CDH1）プロモーター領域のメチル化との関連"}]},"item_type_id":"3","owner":"11","path":["976"],"pubdate":{"attribute_name":"公開日","attribute_value":"2019-11-22"},"publish_date":"2019-11-22","publish_status":"0","recid":"5789","relation_version_is_last":true,"title":["2 型糖尿病長期罹患により膵導管癌患者の予後は増悪する：E-cadherin1 （CDH1）プロモーター領域のメチル化との関連"],"weko_creator_id":"11","weko_shared_id":-1},"updated":"2023-05-16T05:59:17.980677+00:00"}